Prognosis of Multiple Myeloma Has Improved Since 2000
MONDAY, April 24, 2023 (HealthDay News) — For patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in BMC Cancer.Christine Eisf…
Learn MoreMinimal Residual Disease Negativity Predicts Time to Next Treatment in Multiple Myeloma
WEDNESDAY, March 22, 2023 (HealthDay News) — For patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTNT), according to a st…
Learn MoreIde-Cel Beneficial in Relapsed, Refractory Multiple Myeloma
FRIDAY, Feb. 10, 2023 (HealthDay News) — For patients with pretreated relapsed and refractory multiple myeloma, idecabtagene vicleucel (ide-cel), a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy, prolongs progression-free…
Learn MoreAlternative to Lenalidomide ID’d for Maintenance in Multiple Myeloma
WEDNESDAY, Feb. 1, 2023 (HealthDay News) — For patients with newly diagnosed multiple myeloma after induction treatment and autologous stem cell transplantation, maintenance therapy with carfilzomib, lenalidomide, and dexamethasone may be better than…
Learn MoreBody Mass Index Tied to Multiple Myeloma Survival
FRIDAY, Jan. 20, 2023 (HealthDay News) — Underweight and severe obesity are associated with decreased survival in patients with multiple myeloma (MM), according to a study published online Jan. 12 in the Blood Cancer Journal.Urvi A. Shah, M.D., from …
Learn MoreInflammatory-Nutritional Score Helps Predict Survival in New Multiple Myeloma
FRIDAY, Jan. 20, 2023 (HealthDay News) — For patients with newly diagnosed multiple myeloma (NDMM), a nomogram based on the inflammatory-nutritional score (INS) may help to predict survival, according to a study published online Jan. 5 in the Journal…
Learn MoreInflammatory-Nutritional Score Helps Predict Survival in New Multiple Myeloma
FRIDAY, Jan. 20, 2023 (HealthDay News) — For patients with newly diagnosed multiple myeloma (NDMM), a nomogram based on the inflammatory-nutritional score (INS) may help to predict survival, according to a study published online Jan. 5 in the Journal…
Learn MoreMass Spectrometry Can Monitor Treatment Response in Multiple Myeloma
THURSDAY, Jan. 19, 2023 (HealthDay News) — For patients with newly diagnosed multiple myeloma (MM), mass spectrometry (MS) can monitor treatment response, according to a study published online Jan. 4 in Blood Cancer Journal.Elias K. Mai, M.D., from H…
Learn MoreDelay in Time to Antibiotics Permissible for Inpatient Neutropenic Fever
MONDAY, Jan. 9, 2023 (HealthDay News) — For patients with hematologic malignancy who develop inpatient neutropenic fever, delays in time to antibiotics do not significantly affect overall survival at 180 days, according to a study published in the Ja…
Learn MoreAmerican Society of Hematology, Dec. 10 to 13
The annual meeting of the American Society of Hematology was held from Dec. 10 to 13 in New Orleans and attracted participants from around the world, including hematology specialists as well as clinical practitioners and other health care professiona…
Learn More